Single-use chromatography combines a reusable instrument platform with a pre-sterilized, disposable flow path that is exchanged between runs. By eliminating every wetted surface that carries contamination risk from one campaign to the next, these systems remove the need for cleaning validation of the flow path, reduce the time between product changeovers, and enable multiproduct facilities to run successive programs without the cross-contamination concerns that stainless steel infrastructure introduces. As biopharma manufacturing shifts toward smaller batch sizes, higher modality diversity, and faster clinical timelines, single-use chromatography has moved from a clinical-phase convenience to a commercially viable platform technology.
Quick Take
- The disposable flow path - tubing, sensors, connectors, and fluid treatment components - replaces cleaning validation with a pre-sterilized, single-use assembly that is discarded after each campaign
- Prepacked single-use columns eliminate column packing, packing qualification, and the expertise and equipment required to reproduce bed performance in-house
- Integration with single-use bioreactors and buffer systems enables fully disposable downstream trains from harvest to bulk drug substance
- Leachables and extractables compliance is a non-negotiable qualification requirement; USP chapter 665, which became enforceable in May 2026, defines the current mandatory US standard for plastic components in pharmaceutical manufacturing
- Changeover time reduction is the most immediate operational benefit - multiproduct facilities can move between programs in hours rather than days when cleaning and requalification are removed from the critical path
How Single-Use Chromatography Systems Are Engineered
A single-use chromatography system separates the instrument - pumps, detectors, valves, and control electronics - from the fluid path. The instrument is permanent and reusable; the flow path is pre-assembled, pre-sterilized, and discarded after use. This architecture is the core engineering principle that eliminates cleaning validation: every surface that contacts product or process fluid is either new at the start of each run or separated from the product by validated barrier materials.
Working in analytical science?
Register for a FREE Separation Science account to subscribe to the Separation Science Newsletter.
The disposable flow path covers all wetted components, including inlet and outlet tubing, pressure sensors, UV flow cells, conductivity sensors, air traps, and all connectors between them. Modern designs pre-assemble and gamma-irradiate these components as a single unit, which the operator connects to the instrument without breaching sterility. Automated installation verification checks - confirming correct component orientation and connector engagement - reduce the operator interaction risk that manual assembly introduced in earlier single-use designs. The result is a system where the primary GMP concern shifts from cleaning to incoming component qualification and material compatibility rather than residue carryover between campaigns.
Prepacked Columns: Eliminating In-House Packing and Its Validation Burden
The column is the most technically demanding component in any chromatography step, and in-house column packing introduces variability that requires extensive qualification to control. Bed height, packing pressure, slurry concentration, adapter positioning, and operator technique all affect the resulting asymmetry and theoretical plate count. In a GMP environment, each column must be packed to a validated specification and tested against release criteria before use - a process that requires dedicated equipment, trained personnel, and documentation that does not directly contribute to product manufacturing.
Prepacked single-use columns transfer that burden to the column supplier. Packed under controlled conditions in ISO-classified clean rooms using validated procedures, prepacked columns arrive with a certificate of conformance covering bed performance, resin identity, and materials of construction. The end user validates the column format, not the packing process. This distinction significantly reduces the qualification scope for new programs and enables facilities to implement new resin chemistries without first developing in-house packing procedures. For multiproduct facilities, prepacked columns also provide inventory flexibility - columns can be ordered to specification for each campaign without maintaining packing expertise for every resin type in the portfolio. The relationship between prepacked column selection and downstream performance connects directly to resin chemistry and scale-up strategy, where column format and resin selection interact to determine step yield and throughput at commercial scale.
GMP Integration: Cleaning Validation Elimination and Regulatory Expectations
The elimination of cleaning validation for the flow path is the most significant regulatory advantage of single-use chromatography - but it requires understanding what is and is not eliminated. Cleaning validation of the disposable flow path itself is replaced by the component qualification program: the supplier must demonstrate that materials of construction are compatible with process fluids, that the sterilization method does not generate harmful residuals, and that extractables and leachables profiles meet patient safety thresholds. The user must qualify incoming lots and maintain supplier change notification agreements.
The distinction between extractables and leachables is precise and operationally important. Extractables are compounds that can be released from plastic components under exaggerated or forced conditions; leachables are compounds that actually migrate into the drug substance under normal process conditions. USP general chapter 665, which became enforceable on May 1, 2026, is the first compendial US standard defining the extraction conditions, analytical evaluation thresholds, and documentation requirements for plastic components used in pharmaceutical manufacturing - including chromatography columns, tubing, connectors, and all other single-use flow path components. Compliance with USP 665 is now a mandatory requirement for regulatory submissions that include single-use chromatography systems, and gaps in leachables documentation are among the most frequently cited technical deficiencies in biologic drug applications.
Column packing equipment cleaning validation is a separate topic that BioPhorum addressed in a 2024 position paper establishing that, under a risk-based framework, cleaning of empty chromatography columns and packing equipment does not require formal cleaning validation when adequate in-process controls are in place. This position has been adopted by multiple industry organizations and reduces the validation burden for facilities that continue to use both self-packed and prepacked columns within the same downstream platform.
Changeover Efficiency in Multiproduct Facilities
The operational case for single-use chromatography in multiproduct facilities rests primarily on changeover time. In a stainless steel facility, changing between products on a shared chromatography skid requires cleaning the flow path, cleaning verification sampling, analytical testing of cleaning samples, documentation review, and often a waiting period before the next campaign can begin. Depending on facility cleaning procedures and analytical turnaround times, this sequence can extend changeover to several days. When manufacturing schedules are tight and column trains are shared across multiple programs, changeover time directly reduces manufacturing throughput.
Replacing the flow path with a pre-sterilized single-use assembly collapses this sequence. The new flow path is installed, installation verification is completed, and the system can proceed to column equilibration for the next campaign without waiting for cleaning analytics. For facilities running multiple antibody programs through the same Protein A capture step and downstream polishing sequence, this compression of changeover time is a direct improvement in facility utilization. The economic value is most visible in clinical manufacturing, where batch sizes are small, program diversity is high, and the cost of schedule delays relative to batch value is disproportionately large.
Integrating Single-Use Skids into a Fully Disposable Downstream Train
Single-use chromatography reaches its full operational value when integrated with the rest of a disposable downstream train rather than deployed as an isolated step. When the cell culture harvest arrives in single-use bags from a single-use bioreactor, passes through single-use depth filtration and viral inactivation steps, and then enters a single-use chromatography skid with a prepacked column, the facility achieves a continuous chain of disposability from upstream output to purified bulk. Each handoff between steps that would otherwise require a cleaned and validated stainless steel vessel or transfer line becomes a single-use connector or bag weld.
This integration has engineering requirements. Flow paths must be compatible across steps in terms of connector formats, maximum operating pressures, and material composition. Buffer management systems feeding the chromatography skid must be capable of delivering the volumes and conductivities required for loading, washing, and elution without introducing stainless steel holding tanks that break the disposable train. The scale at which fully disposable trains are practical is constrained by the available sizes of single-use columns and flow path components - currently extending to column diameters up to 80 cm in prepacked formats - and by the cost structure of consumables at commercial scale compared to stainless steel amortization. For clinical and early commercial production, the economics consistently favor the disposable approach; at very high commercial volumes, a hybrid model using single-use flow paths with reusable column hardware is often the practical compromise.
Single-Use Chromatography in GMP Manufacturing: Considerations for Downstream Scientists
Single-use chromatography eliminates cleaning validation of the flow path, transfers column packing qualification to the supplier, and compresses campaign changeover times - three advantages that are most valuable in multiproduct, high-throughput GMP environments. The qualifying conditions for single-use systems have become more precisely defined since USP 665 became enforceable in 2026, making a structured extractables and leachables program a mandatory part of any regulatory submission that includes single-use flow path components. For downstream scientists integrating single-use skids into a broader purification strategy, the downstream purification sequence - from capture through polishing - is the unit of optimization, and the single-use architecture of the skid is one variable within that larger system rather than an end in itself.
This article was produced under Separation Science's AI Editorial Guidelines.
